Amination of phosphines

A novel synthesis method for phosphinimine compounds using hydroxylamine reagents and a Bronsted base avoids hazardous chemicals, enabling the production of highly active single site polymerization catalysts.

WO2026234533A1PCT designated stage Publication Date: 2026-11-12NOVA CHEM (INT) SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2026/054341
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-06
Filing Date
2026-05-01
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing methods for synthesizing phosphinimine compounds often require chlorinated solvents and involve the use of energetic azide compounds or ammonia gas, which can be hazardous and environmentally unfriendly.

Method used

A method for synthesizing phosphinimine compounds using phosphines, hydroxylamine reagents, and a Bronsted base without the need for chlorinated solvents or energetic azide compounds, utilizing hydroxylamine reagents like hydroxylamine-O-sulfonic acid (HOSA) and O-diphenylphosphinylhydroxylamine.

Benefits of technology

The method provides a safer and more environmentally friendly synthesis of phosphinimine compounds, suitable for producing highly active single site polymerization catalysts.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000001_0001
    Figure IMGF000001_0001
  • Figure IMGF000001_0002
    Figure IMGF000001_0002
  • Figure IMGF000002_0001
    Figure IMGF000002_0001
Patent Text Reader

Abstract

Provided are synthetic methods to make phosphinimine compounds which may serve as pre-metallation compounds which can be used to make single site polymerization catalysts.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] AMINATION OF PHOSPHINES

[0002] TECHNICAL FIELD

[0003] Synthetic methods for the preparation of phosphinimine compounds are provided. The phosphinimine compounds may afford highly active single site polymerization catalysts on reaction with a group 4 metal compound.

[0004] BACKGROUND ART

[0005] The direct amination of triaryl phosphines is known. In U.S. Pat. No. 4,767,749 treatment of a triphenylphosphine with hydroxylamine O-sulfonic acid (HOSA) provided as product, a triphenyl phosphinimine compound.

[0006] SUMMARY OF INVENTION

[0007] Provided is a method for making phosphinimine compounds from phosphines and which can be carried out in the absence of chlorinated solvents and does not involve the use energetic azide compounds or ammonia gas as reagents.

[0008] An embodiment of the disclosure is a method for making a phosphinimine compound having the formula I,

[0009]

[0010] the method comprising:

[0011] combining a phosphine compound having the formula II,

[0012]

[0013] hydroxylamine reagent and a Bronsted base; wherein the hydroxylamine reagent is selected from the group consisting of:

[0014] 0

[0015] HO - y_O— NH2

[0016] (Illa),R* - y_O— NH2

[0017] (Illb),

[0018] 0

[0019] R* - LO-NH2(IIIc)

[0020]

[0021] ( );

[0022] wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group;

[0023] wherein RAis a primary alkyl group, or a secondary alkyl group, or a tertiary alkyl group; and

[0024] wherein RBand RCare each independently selected from

[0025] a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; anda heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group.

[0026] An embodiment of the disclosure is a method for making a phosphinimine compound having the formula IV,

[0027]

[0028] double bond isomers of formula IV which are available by migration of the hydrogen, H* within the cyclopentadiene ring structure; the method comprising:

[0029] combining a phosphine compound having the formula V,

[0030]

[0031] hydroxylamine reagent and a Bronsted base; wherein the hydroxylamine reagent is selected from the group consisting of:

[0032]

[0033] (Illa),0

[0034] R* - y_0— NH2

[0035] (Illb),

[0036] 0

[0037] R* - LO-NH2(IIIc)

[0038]

[0039] wherein each R* is independently a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and wherein R1and R2are each independently a C1.30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;wherein R3, R4, R5and R6are each independently selected from the group consisting of

[0040] a hydrogen atom;

[0041] a fluorine atom;

[0042] a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0043] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0044] wherein two adjacent groups of R3, R4, R5and R6may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group; and

[0045] wherein L is a bridging group.

[0046] An embodiment of the disclosure is a method for making a phosphinimine compound having the formula VI,the method comprising:

[0047] combining a phosphine compound having the formula VII,

[0048]

[0049] hydroxylamine reagent and a Bronsted base;

[0050] wherein the hydroxylamine reagent is selected from the group consisting of: 0

[0051] HO - y_ o— NH2

[0052] (Illa),

[0053]

[0054] (IIIe),

[0055]

[0056] wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and wherein R1and R2are each independently a C1.30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0057] wherein R11, R12, R13, R14, R15, R16, R17and R18are each independently selected from the group consisting of

[0058] a hydrogen atom;

[0059] a fluorine atom;

[0060] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0061] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0062] wherein two adjacent groups of R11, R12, R13, R14, R15, R16, R17and R18may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containinghydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and wherein L is a bridging group.

[0063] In embodiments of the disclosure, the hydroxylamine reagent used is

[0064] 0

[0065] HO - y_O— NH2

[0066] O (Illa).

[0067] DESCRIPTION OF EMBODIMENTS

[0068] As used herein, the term “monomer” refers to a small molecule that may chemically react and become chemically bonded with itself or other monomers to form a polymer.

[0069] As used herein, the term “a-olefin” or “alpha-olefin” is used to describe a monomer having a linear hydrocarbon chain containing from 3 to 20 carbon atoms having a double bond at one end of the chain; an equivalent term is “linear a-olefin”. As used herein, the term “polyethylene” or “ethylene polymer”, refers to macromolecules produced from ethylene monomers and optionally one or more additional monomers; regardless of the specific catalyst or specific process used to make the ethylene polymer. In the polyethylene art, the one or more additional monomers are called “comonomer(s)” and often include a-olefins. The term “homopolymer” refers to a polymer that contains only one type of monomer. An “ethylene homopolymer” is made using only ethylene as a polymerizable monomer. The term “copolymer” refers to a polymer that contains two or more types of monomer. An “ethylene copolymer” is made using ethylene and one or more other types of polymerizable monomer. Common polyethylenes include high density polyethylene (HDPE), medium density polyethylene (MDPE), linear low density polyethylene (LLDPE), very low density polyethylene (VLDPE), ultralow density polyethylene (ULDPE), plastomers and elastomers. The term polyethylene also includes polyethylene terpolymers which may include two or more comonomers in addition to ethylene. The term polyethylene also includes combinations of, or blends of, the polyethylenes described above.

[0070] As used herein, the terms “hydrocarbyl”, “hydrocarbyl radical” or “hydrocarbyl group” refers to linear, branched, cyclic, acyclic, aliphatic, olefinic (i.e., has double bondunsaturation), acetylenic (i.e., has triple bond unsaturation) and aryl (aromatic) groups comprising hydrogen and carbon that are deficient by at least one hydrogen atom. Hence a person skilled in the art will understand that “hydrocarbyl group” includes by way of providing non-limiting examples, alkyl groups, which may be primary, secondary (such as for example a cycloalkyl group), or tertiary alkyl groups; alkenyl groups; alkynyl groups; and aryl groups. The term “cyclic hydrocarbyl group” is a subset of the term “hydrocarbyl group” and specifically connotes hydrocarbyl groups that comprise at least one cyclic moiety and which may have one or more than one aromatic ring, and / or one or more than one non-aromatic ring present within them. The term “acyclic hydrocarbyl group” is a subset of the term “hydrocarbyl group” and specifically connotes hydrocarbyl groups that do not have cyclic moieties such as aromatic or non-aromatic ring structures present within them.

[0071] As used herein, the term “heteroatom” includes any atom other than carbon and hydrogen that can be bound to carbon. The term “heteroatom containing” or “heteroatom containing hydrocarbyl group” means that one or more than one non carbon atom, not including a hydrogen atom, is present in the hydrocarbyl group. Some non-limiting examples of non-carbon atoms (and non-hydrogen atoms) that may be present is a heteroatom containing hydrocarbyl group are N, O, S, P and Si as well as halides such as for example F and / or Br as well as metals such as Sn. Some non-limiting examples of heteroatom containing hydrocarbyl groups include for example hydrocarbyl groups having an oxy moiety present, a thiol moiety present, a nitro moiety present, a silyl moiety present, an imine moiety present, an amido moiety present. Further non-limiting examples of heteroatom containing hydrocarbyl groups include for example alkoxide moieties, phenoxide moieties, amine moieties, carbonyl moieties, phosphine moieties, ether moieties, ketone moieties, heterocyclics structures, oxazoline moieties, thioether moieties, and the like. The term “cyclic heteroatom containing hydrocarbyl group” is a subset of the term “heteroatom containing hydrocarbyl group” and specifically connotes heteroatom containing hydrocarbyl groups that comprise at least one cyclic moiety and which may have one or more than one aromatic ring, and / or one or more than one non-aromatic ring present within them. The term “acyclic heteroatom containing hydrocarbyl group” is a subset of the term “heteroatom containing hydrocarbyl group” and specifically connotes heteroatom containing hydrocarbyl groups that do not have cyclic moieties such as aromatic or non-aromatic ring structures present within them.In an embodiment of the disclosure, a heteroatom containing hydrocarbyl group is a hydrocarbyl group containing from 1 to 3 atoms selected from the group consisting of boron, aluminum, silicon, germanium, nitrogen, phosphorous, oxygen and sulfur.

[0072] In an embodiment of the disclosure, a cyclic heteroatom containing hydrocarbyl group is a cyclic hydrocarbyl group containing from 1 to 3 atoms selected from the group consisting of boron, aluminum, silicon, germanium, nitrogen, phosphorous, oxygen and sulfur.

[0073] The term “heterocyclic group” is a subset of the term “cyclic heteroatom containing hydrocarbyl group” and specifically refers to ring systems having a carbon backbone that further comprises at least one heteroatom selected from the group consisting of for example boron, aluminum, silicon, germanium, nitrogen, phosphorous, oxygen and sulfur within a ring structure.

[0074] As used herein, an “alkyl radical” or “alkyl group” includes linear, branched and cyclic paraffin groups that are deficient by one hydrogen group; non-limiting examples include methyl (-CH3) and ethyl (-CH2CH3) groups, which are non-limiting examples of primary alkyl groups; iso-propyl and cyclohexyl groups, which are non-limiting examples of secondary alkyl groups; and a tert-butyl group, which is a non-limiting example of a tertiary alkyl group. The term “alkenyl radical” or “alkenyl group” refers to linear, branched and cyclic hydrocarbons containing at least one carbon-carbon double bond that is deficient by one hydrogen group. The term “alkynyl radical” or “alkynyl group” refers to linear, branched and cyclic hydrocarbons containing at least one carbon-carbon triple bond that is deficient by one hydrogen group.

[0075] As used herein, the term “aryl radical” or “aryl group” includes phenyl, naphthyl, pyridyl and other groups whose molecules have an aromatic ring structure; non-limiting examples include naphthalene, phenanthrene and anthracene.

[0076] An “arylalkyl” is a subset of an “alkyl group” and is an alkyl group having an aryl group pendant there from; non-limiting examples include benzyl, phenethyl and tolylmethyl. An “alkylaryl” group is a subset of an “aryl group” and is an aryl group having one or more alkyl groups pendant there from; non-limiting examples include tolyl, xylyl, mesityl and cumyl.

[0077] An “alkoxy group” is an oxy group having an alkyl group pendant there from; and includes for example a methoxy group, an ethoxy group, an iso-propoxy group, and the like. An “arylalkyloxy group” is an oxy group having an arylalkyl group pendent there from (forclarity, the alkyl moiety is bonded to the oxy moiety and the aryl group is bonded to the alkyl moiety).

[0078] An “aryloxy” group is an oxy group having an aryl group pendant there from; and includes for example a phenoxy group and the like. An “alkylaryloxy group” is an oxy group having an alkylaryl group pendent there from (for clarity, the aryl moiety is bonded to the oxy moiety and the alkyl group is bonded to the aryl moiety).

[0079] In the present disclosure, a hydrocarbyl group or a heteroatom containing hydrocarbyl group (or subsets of these groups, such as alkyl groups, alkoxy groups, aryl groups, aryloxy groups, etc.) may be further specifically defined as being unsubstituted or substituted. As used herein the term “unsubstituted” means that hydrogen groups are bound to the molecular group that is referred to by the term unsubstituted. The term “substituted” means that the group referred to by this term possesses one or more moieties that have replaced one or more hydrogen groups in any position within the group; non-limiting examples of moieties include halogen groups (F, Cl, Br), an alkyl group, an alkylaryl group, an arylalkyl group, an alkoxy group, an aryl group, an aryloxy group, an amido group, a silyl group or a germanyl group, hydroxyl groups, carbonyl groups, carboxyl groups, amine groups, phosphine groups, phenyl groups, naphthyl groups, Ci to Cio alkyl groups, C2 to C10 alkenyl groups, and combinations thereof.

[0080] In embodiments of the disclosure, any hydrocarbyl group and / or any heteroatom containing hydrocarbyl group may be unsubstituted or substituted.

[0081] In embodiments of the present disclosure, methods are provided to make phosphinimine compounds.

[0082] In embodiments of the present disclosure, methods are provided to make single site polymerization catalysts (also known as pre-polymerization catalysts).

[0083] In an embodiment of the disclosure a method for making a phosphinimine compound having the formula I,

[0084]

[0085] comprises combining a phosphine compound having the formula II,

[0086]

[0087] hydroxylamine reagent and a Bronsted base; wherein the hydroxylamine reagent is selected from the group consisting of:

[0088]

[0089] ,

[0090] wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a Ci-3o alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group;

[0091] wherein RAis a primary alkyl group, or a secondary alkyl group, or a tertiary alkyl group;

[0092] wherein RBand RCare each independently selected from

[0093] a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and

[0094] a heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group.

[0095] In an embodiment of the disclosure a method for making a phosphinimine compound having the formula I-2P,

[0096]

[0097] comprises combining a phosphine compound having the formula II-2P,

[0098]

[0099] hydroxylamine reagent and a Bronsted base; wherein the hydroxylamine reagent is selected from the group consisting of:

[0100]

[0101] ,

[0102] wherein each R* is independently a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1-30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group;wherein RD, RE, RF, and RGare each independently selected from

[0103] a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a Ci-3o alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and

[0104] a heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group;

[0105] and wherein LG is a linking group.

[0106] In an embodiment of the disclosure a method for making a phosphinimine compound having the having the formula IV,

[0107]

[0108] double bond isomers of formula IV which are available by migration of the hydrogen, H* within the cyclopentadiene ring structure; comprises combining a phosphine compound having the formula V,

[0109]

[0110] hydroxylamine reagent and a Bronsted base; wherein the hydroxylamine reagent is selected from the group consisting of:

[0111]

[0112] wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and wherein R1and R2are each independently a C1.30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0113] wherein R3, R4, R5and R6are each independently selected from the group consisting of

[0114] a hydrogen atom;

[0115] a fluorine atom;

[0116] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20arylalkyl group, a Ce-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0117] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0118] wherein two adjacent groups of R3, R4, R5and R6may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group; and

[0119] wherein L is a bridging group.

[0120] In an embodiment of the disclosure a method for making a phosphinimine compound having the having the formula VI,

[0121]

[0122] comprises combining a phosphine compound having the formula VII,

[0123]

[0124] hydroxylamine reagent and a Bronsted base; wherein the hydroxylamine reagent is selected from the group consisting of:

[0125]

[0126] wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1-30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group;

[0127] wherein R1and R2are each independently a C1-30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1-20 alkyl group, a C1-20 alkoxy group, a C7-20alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0128] wherein R11, R12, R13, R14, R15, R16, R17and R18are each independently selected from the group consisting of

[0129] a hydrogen atom;

[0130] a fluorine atom;

[0131] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0132] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0133] wherein two adjacent groups of R11, R12, R13, R14, R15, R16, R17and R18may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and wherein L is a bridging group.

[0134] Further embodiments of the R* group, each occurrence, which can be used in embodiments of the present disclosure, including any combinations thereof, and with regard to the hydroxylamine reagent having the formula (IIIb), (IIIc), (IIId), and (IIIe) are described as follows.

[0135] In an embodiment each R* is independently an aryl group, which aryl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.In an embodiment each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0136] In an embodiment, each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitro group.

[0137] In an embodiment, each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one halide atom.

[0138] In an embodiment, each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitrile group.

[0139] In an embodiment, each R* is independently an unsubstituted phenyl group.

[0140] In an embodiment, each R* is an alkyl group, which alkyl group is unsubstituted or further substituted by one or a fluorine atom.

[0141] In an embodiment, each R* is a primary alkyl group which alkyl group is unsubstituted or further substituted by one or more than one fluorine atom.

[0142] In an embodiment, each R* is a primary alkyl group which alkyl group is further substituted by one or more than one fluorine atom.

[0143] In an embodiment, each R* is a perfluoro alkyl group.

[0144] In an embodiment, each R* is CF3.

[0145] In an embodiment, the hydroxylamine reagent is hydroxylamine-O-sulfonic acid, 0

[0146] HO - y_ 0— NH2

[0147] u(Illa). The reagent hydroxylamine-O-sulfonic acid may abbreviated as “HOSA”.

[0148] In an embodiment, the hydroxylamine reagent is O-diphenylphosphinylhydroxylamine,

[0149]

[0150] (Illh).

[0151] In an embodiment, the hydroxylamine reagent is O-(4-nitrobenzoyl)hydroxylamine,

[0152]

[0153] (Illi).

[0154] In an embodiment, the hydroxylamine reagent is O-(2,4-dinitrophenyl)hydroxylamine,

[0155]

[0156] In an embodiment, RBand RCare each independently selected from

[0157] a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0158] In an embodiment, RBand RCare each independently selected from a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0159] In an embodiment, RBand RCare each independently selected from a C1.30 heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group.

[0160] In an embodiment, RBand RCare each, independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

[0161] In an embodiment, RBand RCare each, independently selected from the group consisting of a C1.30 primary alkyl group, a C3-30 secondary alkyl group, and a C4-30 tertiary alkyl group.

[0162] In an embodiment, RAand RBand RCare each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.In an embodiment, RAand RBand RCare each independently selected from the group consisting of a C3-30 secondary alkyl group, and a C4-30 tertiary alkyl group.

[0163] In an embodiment, RAand RBand RCare each independently a secondary alkyl group.

[0164] In an embodiment, RAand RBand RCare each independently C3-30 secondary alkyl group.

[0165] In an embodiment, RAand RBand RCare each a tertiary alkyl group.

[0166] In an embodiment, RAand RBand RCare each a C4-30 tertiary alkyl group.

[0167] In an embodiment, RAand RBand RCare each independently selected from the group consisting of an isopropyl group, a cyclohexyl group, an adamantly group, and a tert-butyl group.

[0168] In an embodiment, RAand RBand RCare each an isopropyl group.

[0169] In an embodiment, RAand RBand RCare each a cyclohexyl group.

[0170] In an embodiment, RAand RBand RCare each a tert-butyl group.

[0171] In an embodiment, RAand RBand RCare each an adamantyl group.

[0172] In an embodiment, RDis a primary alkyl group, or a secondary alkyl group, or a tertiary alkyl group; RFis a primary alkyl group, or a secondary alkyl group, or a tertiary alkyl group; and

[0173] REand RGare each independently selected from

[0174] a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and

[0175] a heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group.

[0176] In an embodiment, RD, RE, RFand RGare each independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.In an embodiment, RD, RE, RFand RGare each independently selected from the group consisting of a C1.30 primary alkyl group, a C3-30 secondary alkyl group, and a C4-30 tertiary alkyl group.

[0177] In an embodiment, RD, RE, RFand RGare each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

[0178] In an embodiment, RD, RE, RFand RGare each independently selected from the group consisting of a C3-30 secondary alkyl group, and a C4-30 tertiary alkyl group.

[0179] In an embodiment, RD, RE, RFand RGare each a secondary alkyl group.

[0180] In an embodiment, RD, RE, RFand RGare each a C3-30 secondary alkyl group.

[0181] In an embodiment, RD, RE, RFand RGare each a tertiary alkyl group.

[0182] In an embodiment, RD, RE, RFand RGare each a C4-30 tertiary alkyl group.

[0183] In embodiments of the disclosure, LG is a linking group comprising 1 to 50 atoms. In embodiments of the disclosure, LG is a linking group selected from

[0184] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; or a

[0185] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0186] In an embodiment, LG is a linking group containing a contiguous chain of 2 or 3 or 4 or 5 atoms connecting P (a first phosphorus atom) with the P* (a second phosphorus atom). By the phrase “contiguous chain of 2 or 3 or 4 or 5 atoms” it is meant that the atoms being referred to are bonded together in sequence, and to P at one end, and to P* at the other end. By way of example, a contiguous chain of 2 atoms bonded together in sequence, and to P at one end, and to P* at the other end, includes P — atom 1 — atom 2 — P*, with each of atom 1 and / or atom 2 optionally having additional atom(s) bonded to atom 1 and / or atom 2 (e.g., hydrogen, carbon, nitrogen, oxygen, etc.) but not having the additional atoms positioned between atom 1 and atom 2. By way of another example, a contiguous chain of 3 atoms bonded together in sequence, and to P at one end, and to P* at the other end, includes P — atom 1 — atom 2 — atom 3 — P*, with each of atom 1, atom 2, and / or atom 3 optionallyhaving additional atom(s) bonded to atom 1, atom 2, and / or atom 3 (e.g., hydrogen, carbon, nitrogen, oxygen, etc.) but not having the additional atoms positioned between atom 1 and atom 2 and between atom 2 and atom 3. Additionally, when LG is a linking group containing a contiguous chain of 2 or 3 or 4 or 5 atoms connecting P with the P*, LG may have more than one contiguous chain of atoms connecting P with P* so long as LG contains somewhere in its structure a contiguous chain of only 2 or only 3 or only 4 or only 5 atoms connecting P with P*.

[0187] In some embodiments, LG is a linking group containing a contiguous chain of 3 atoms connecting P with P*. In some embodiments, LG is a linking group containing a contiguous chain of 2 atoms connecting P with P*. By the phrases “contiguous chain of 3 atoms” and “contiguous chain of 2 atoms”, it is meant that the atoms being referred to are bonded together in sequence, and to P at one end, and to P* at the other end.

[0188] In embodiments of the disclosure, LG is a linking group containing a contiguous chain of 2 or 3 or 4 or 5 carbon atoms connecting P with P*. In some embodiments, LG is a linking group containing a contiguous chain of 3 carbon atoms connecting P with P*. In some embodiments, LG is a linking group containing a contiguous chain of 2 carbon atoms connecting P with P*.

[0189] In an embodiment, LG is

[0190]

[0191] wherein ^ A / W' indicates the point of attachment to P and (*) indicates the point of attachment to P*;

[0192] wherein RH, RI, RJ, and RKare each independently selected from the group consisting of

[0193] a hydrogen atom;

[0194] a fluorine atom;

[0195] a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; anda heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0196] wherein two adjacent groups of RH, RI, RJ, and RKmay optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0197] In embodiments, RH, RI, RJ, and RKare each independently selected from the group consisting of

[0198] a hydrogen atom; and

[0199] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0200] wherein two adjacent groups of RH, RI, RJ, and RKmay optionally be bonded to form a cyclic hydrocarbyl group, the cyclic hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group.

[0201] In an embodiment RH, RI, RJ, and RKare each hydrogen.

[0202] In an embodiment, LG is

[0203]

[0204] wherein '' / vvv-v-' indicates the point of attachment to P and (*) indicates the point of attachment to P*.Further embodiments of the R1and R2groups, which can be used in embodiments of the present disclosure, including any combinations thereof, and with regard to the phosphine compounds such as V and VII as well as phosphinimine compounds such as IV and VI are described as follows.

[0205] In an embodiment, R1and R2are each, independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

[0206] In an embodiment, R1and R2are each, independently selected from the group consisting of a C1.30 primary alkyl group, a C3-30 secondary alkyl group, and a C4-30 tertiary alkyl group.

[0207] In an embodiment, R1and R2are each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

[0208] In an embodiment, R1and R2are each independently selected from the group consisting of a C3-30 secondary alkyl group, and a C4-30 tertiary alkyl group.

[0209] In embodiments, each of R1and R2is a secondary alkyl group.

[0210] In embodiments, each of R1and R2is a C3-30 secondary alkyl group.

[0211] In embodiments, each of R1and R2is a tertiary alkyl group.

[0212] In embodiments, each of R1and R2is a C4-30 tertiary alkyl group.

[0213] In an embodiment, R1and R2are each independently selected from the group consisting of an isopropyl group, a cyclohexyl group, an adamantly group, and a tert-butyl group.

[0214] In an embodiment, R1and R2are each an isopropyl group.

[0215] In an embodiment, R1and R2are each a cyclohexyl group.

[0216] In an embodiment, R1and R2are each a tert-butyl group.

[0217] In embodiments of the disclosure, L is a bridging group comprising 1 to 50 atoms. In embodiments of the disclosure, L is a bridging group selected from

[0218] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; or a

[0219] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0220] In embodiments of the disclosure, L is a bridging group containing a contiguous chain of 2 or 3 atoms connecting P with the cyclopentadiene ring structure (herein “Cy” for short). By the phrase “contiguous chain of 2 or 3 atoms” it is meant that the atoms being referred to are bonded together in sequence, and to P at one end, and to the cyclopentadiene ring structure at the other end. By way of example, a contiguous chain of 2 atoms bonded together in sequence, and to P at one end, and to the cyclopentadiene ring structure at the other end, includes P — atom 1 — atom 2 — Cy, with each of atom 1 and / or atom 2 optionally having additional atom(s) bonded to atom 1 and / or atom 2 (e.g., hydrogen, carbon, nitrogen, oxygen, etc.) but not having the additional atoms positioned between atom 1 and atom 2. By way of another example, a contiguous chain of 3 atoms bonded together in sequence, and to P at one end, and to the cyclopentadiene ring structure at the other end, includes P — atom 1 — atom 2 — atom 3 — Cy, with each of atom 1, atom 2, and / or atom 3 optionally having additional atom(s) bonded to atom 1, atom 2, and / or atom 3 (e.g., hydrogen, carbon, nitrogen, oxygen, etc.) but not having the additional atoms positioned between atom 1 and atom 2 and between atom 2 and atom 3. Additionally, when L is a bridging group containing a contiguous chain of 2 or 3 atoms connecting P with the cyclopentadiene ring structure, L may have more than one contiguous chain of atoms connecting P with the cyclopentadiene ring structure so long as L contains somewhere in its structure a contiguous chain of only 2 or only 3 atoms connecting P with the cyclopentadiene ring structure.

[0221] In some embodiments, L is a bridging group containing a contiguous chain of 3 atoms connecting P with Cy. In some embodiments, L is a bridging group containing a contiguous chain of 2 atoms connecting P with Cy. By the phrases “contiguous chain of 3 atoms” and “contiguous chain of 2 atoms”, it is meant that the atoms being referred to are bonded together in sequence, and to P at one end, and to Cy at the other end.

[0222] In embodiments of the disclosure, L is a bridging group containing a contiguous chain of 2 or 3 carbon atoms connecting P with the cyclopentadiene ring structure (herein “Cy” for short). In some embodiments, L is a bridging group containing a contiguous chain of 3 carbon atoms connecting P with Cy. In some embodiments, L is a bridging group containing a contiguous chain of 2 carbon atoms connecting P with Cy.In an embodiment, L is

[0223]

[0224] wherein ∿∿∿∿ indicates the point of attachment to P and (*) indicates the point of attachment to the cyclopentadiene ring structure;

[0225] wherein R7, R8, R9, and R10are each independently selected from the group consisting of

[0226] a hydrogen atom;

[0227] a fluorine atom;

[0228] a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0229] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0230] wherein two adjacent groups of R7, R8, R9, and R10may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0231] In embodiments, R7, R8, R9, and R10are each independently selected from the group consisting of

[0232] a hydrogen atom; and

[0233] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0234] wherein two adjacent groups of R7, R8, R9, and R10may optionally be bonded to form a cyclic hydrocarbyl group, the cyclic hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group.

[0235] In embodiments, R7, R8, R9, and R10are each independently selected from the group consisting of

[0236] a hydrogen atom; and

[0237] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0238] In an embodiment R7, R8, R9, and R10are each hydrogen.

[0239] In embodiments R3, R4, R5, and R6are each independently selected from the group consisting of

[0240] a hydrogen atom; and

[0241] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0242] wherein two adjacent groups of R3, R4, R5and R6may optionally be bonded to form a cyclic hydrocarbyl group, the cyclic hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group.

[0243] In embodiments R3, R4, R5, and R6are each independently selected from the group consisting of

[0244] a hydrogen atom; anda C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0245] In some embodiments, R3, R4, R5and R6are each independently selected from the group consisting of fluorine, hydrogen, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxide group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group.

[0246] In some embodiments, R3, R4, R5and R6are each independently selected from the group consisting of halogen, hydrogen, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxide group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0247] In some embodiments, R3, R4, R5and R6are each independently selected from the group consisting of fluorine, hydrogen, and a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one fluorine atom.

[0248] In some embodiments, R3, R4, R5and R6are each independently selected from the group consisting of halogen, hydrogen, and a C1.30 heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one fluorine atom.

[0249] In some embodiments, R3, R4, R5and R6are each independently selected from the group consisting of hydrogen and a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one fluorine atom.

[0250] In some embodiments, R3, R4, R5and R6are each independently selected from the group consisting of hydrogen and a C1.30 heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one fluorine atom.

[0251] In some embodiments, R3, R4, R5and R6are each hydrogen.

[0252] In some embodiments, R3, R4, R5and R6are each a C1.30 alkyl group.

[0253] In some embodiments, R3, R4, R5and R6are each a methyl group.

[0254] In embodiments R11, R12, R13, R14, R15, R16, R17and R18are each independently selected from the group consisting of

[0255] a hydrogen atom; anda C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0256] wherein two adjacent groups of R11, R12, R13, R14, R15, R16, R17and R18may optionally be bonded to form a cyclic hydrocarbyl group, the cyclic hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group.

[0257] In embodiments R11, R12, R13, R14, R15, R16, R17and R18are each independently selected from the group consisting of

[0258] a hydrogen atom; and

[0259] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0260] In embodiments, each of R11, R13, R14, R15, R16and R18is a hydrogen atom and each of R12and R17is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0261] In embodiments, each of R11, R13, R14, R15, R16and R18is a hydrogen atom and each of R12and R17is independently a C1.20 alkyl group.

[0262] In embodiments, each of R11, R13, R14, R15, R16and R18is a hydrogen atom and each of R12and R17is a tert-butyl group.

[0263] In embodiments, each of R11, R14, R15, and R18is a hydrogen atom and R12, R13, R16and R17are each independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0264] wherein two adjacent groups of R12, R13, R16and R17may optionally be bonded to form a cyclic hydrocarbyl group, the cyclic hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group.

[0265] In embodiments, each of R11, R14, R15, and R18is a hydrogen atom and R12, R13, R16and R17are each independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0266] In embodiments, each of R11, R14, R15, and R18is a hydrogen atom and R12, R13, R16and R17are each independently a C1.20 alkyl group.

[0267] In embodiments, each of R11, R14, R15, and R18is a hydrogen atom, and adjacent groups of R12and R13, and adjacent groups of R16and R17are:

[0268]

[0269] wherein ~~~~~ marks the point of attachment to adjacent fluorenyl group carbon atoms.

[0270] In embodiments R11, R12, R13, R14, R15, R16, R17and R18are hydrogen.

[0271] In embodiments, the Bronsted base used for production of the phosphinimine compound includes organic alkali metal compounds, such as for example, organolithium compounds such as methyl lithium, ethyl lithium, n-butyl lithium, sec-butyl lithium, tertbutyl lithium, lithium trimethyl silylacetylide, lithium acetylide, trimethyl silylmethyl lithium, vinyl lithium, phenyl lithium and allyl lithium.

[0272] In some embodiments, the Bronsted base used for production of the phosphinimine compound is n-butyl lithium.

[0273] In embodiments, the Bronsted base used for production of the phosphinimine compound includes alkali metal alkoxide compounds, alkali metal phenoxide compounds oralkali metal hydroxides. In embodiments, the Bronsted base used for production of the phosphinimine compound is a sodium alkoxide compound or a lithium alkoxide compound.

[0274] In embodiments the base used for production of the phosphinimine compound is lithium methoxide.

[0275] In embodiments the base used for production of the phosphinimine compound is lithium / .w-propoxide.

[0276] In some embodiments, the Bronsted base used for production of the phosphinimine compound may be organic amine compound, such as for example, methylamine, ethylamine, n-propyl amine, isopropylamine, n-butylamine, tert-butylamine, n-octylamine, n-decylamine, aniline and ethylenediamine, secondary amine compounds such as dimethylamine, diethylamine, di-n-propylamine, di-n-butylamine, di-tert-butylamine, di-n-octylamine, di-n-decylamine, pyrrolidine, hexamethyldisilazane and diphenylamine, and tertiary amine compounds such as trimethylamine, triethylamine, tri-n-propylamine, tri-n-butylamine, diisopropylethylamine, tri-n-octylamine, tri-n-decylamine, triphenylamine, N, N-dimethylaniline, N, N, N', N' -tetramethylethylenediamine, N-methylpyrrolidine, 1,8-Diazabicyclo(5.4.0)undec-7-ene, and 4-dimethylaminopyridine.

[0277] In some embodiments, the Bronsted base used for production of the phosphinimine compound may be an alkali metal amide compound. Such an alkali metal amide compounds include those which may be formed by deprotonation (by reaction of the amine with a suitable alkali metal with concomitant formation of hydrogen gas) of primary amine compounds such as methylamine, ethylamine, n-propylamine, isopropylamine, n-butylamine, tert-butylamine, n-octylamine, n-decylamine, aniline and ethylenediamine, secondary amine compounds such as dimethylamine, diethylamine, di-n-propylamine, di-n-butylamine, di-tert-butylamine, di-n-octylamine, di-n-decylamine, pyrrolidine, hexamethyldisilazane and diphenylamine, and tertiary amine compounds such as trimethylamine, triethylamine, tri-n-propylamine, tri-n-butylamine, diisopropylethylamine, tri-n-octylamine, tri-n-decylamine, triphenylamine, N, N-dimethylaniline, N, N, N', N'-tetramethylethylenediamine, N-methylpyrrolidine, 1,8-Diazabicyclo(5.4.0)undec-7-ene, and 4-dimethylaminopyridine.

[0278] In some embodiments, the Bronsted base used for production of the phosphinimine compound is lithium, sodium or potassium bis(trimethylsilyl)amide.

[0279] In embodiments, the amount of the hydroxylamine reagent used can be a range of about 1 to about 5 moles of base per 1 mole of the phosphine compound having the formula II, V, or VII. In further embodiments, the amount of the hydroxylamine reagent used can bea range of about 1 to about 3 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II, V, or VII; or can be in a range of about 1 to about 2.5 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II, V, or VII; or can be a range of about 1 to about 2 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II, V, or VII; or about 1 mole of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II, V, or VII.

[0280] In embodiments, the amount of the hydroxylamine reagent used can be a range of about 2 to about 5 moles of base per 1 mole of the phosphine compound having the formula II or II-2P. In further embodiments, the amount of the hydroxylamine reagent used can be a range of about 2 to about 3 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II or II-2P; or can be in a range of about 2 to about 2.5 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II or II-2P; or about 2 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II or II-2P.

[0281] In embodiments, the amount of the hydroxylamine reagent used can be a range of about 3 to about 5 moles of base per 1 mole of the phosphine compound having the formula II or II-2P. In further embodiments, the amount of the hydroxylamine reagent used can be a range of about 3 to about 4 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II or II-2P; or can be in a range of about 3 to about 3.5 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II or II-2P; or about 3 moles of hydroxylamine reagent per 1 mole of the phosphine compound having the formula II or II-2P.

[0282] In embodiments, the amount of the Bronsted base used can be a range of about 1 to about 5 moles of Bronsted base per 1 mole of the phosphine compound having the formula II, V, or VII. In further embodiments, the amount of the Bronsted base used can be a range of about 1 to about 3 moles of Bronsted base per 1 mole of the phosphine compound having the formula II, V, or VII; or can be in a range of about 1 to about 2.5 moles of Bronsted base per 1 mole of the phosphine compound having the formula II, V, or VII; or can be a range of about 1 to about 2 moles of Bronsted base per 1 mole of the phosphine compound having the formula II, V, or VII; or about 1 mole of Bronsted base per 1 mole of the phosphine compound having the formula II, V, or VII.

[0283] In embodiments, the amount of the Bronsted base used can be a range of about 2 to about 5 moles of Bronsted base per 1 mole of the phosphine compound having the formulaII or II-2P. In further embodiments, the amount of the Bronsted base used can be a range of about 2 to about 3 moles of Bronsted base per 1 mole of the phosphine compound having the formula II or II-2P; or can be in a range of about 2 to about 2.5 moles of Bronsted base per 1 mole of the phosphine compound having the formula II or II-2P; or can be about 2 moles of Bronsted base per 1 mole of the phosphine compound having the formula II.

[0284] In embodiments, the amount of the Bronsted base used can be a range of about 3 to about 5 moles of Bronsted base per 1 mole of the phosphine compound having the formula II or II-2P. In further embodiments, the amount of the Bronsted base used can be a range of about 3 to about 4 moles of Bronsted base per 1 mole of the phosphine compound having the formula II or II-2P; or can be in a range of about 3 to about 3.5 moles of Bronsted base per 1 mole of the phosphine compound having the formula II or II-2P; or can be about 3 moles of Bronsted base per 1 mole of the phosphine compound having the formula II or II-2P.

[0285] Methods to metallate phosphinimine ligand precursors (such as the phsophinimine compounds discussed above) with group 4 metals to provide organometallic complexes which are useful as pre-polymerization catalysts are well established (see for example, Organometallics 1999, 18, 1116 and WO 2023 / 187552). Such pre-polymerization catalysts are also known as “single site catalysts” or “single site polymerization catalysts”. The term “single site catalyst” is used herein to distinguish their polymerization behavior from polymerization catalysts which are traditionally considered multisite polymerization catalysts such as Ziegler-Natta catalysts or chromium-based catalysts. Persons skilled in the art will understand, for example, that metallocene catalysts, constrained geometry catalysts, and phosphinimine catalysts, are all generally considered “single site catalysts”.

[0286] Metallation reactions may involve electrophilic abstraction of labile leaving groups from suitable group 4 metal precursors, and may involve, for example, the electrophilic abstraction of a halogen atom from a group 4 metal halide compound. Alternatively, metalation reactions may involve protonolysis of labile leaving groups from suitable group 4 metal precursors.

[0287] Metallation pathways may involve an initial deprotonation step (i.e. deprotonation of one or more sites of the phosphinimine compound) using, for example, an organolithium reagent, followed by halide abstraction from group 4 metal precursors, or metalation may be carried out directly, when protonolysis of a labile leaving group from a group 4 metal precursor is possible.In embodiments of the disclosure, a phosphinimine compound is metalated by a direct or indirect reaction with MX14or MX14(THF)2; wherein M is Ti, Zr, or Hf; and wherein each X1is independently selected from a protonolyzable group or a group which can be abstracted by electrophilic abstraction.

[0288] In an embodiment of the disclosure a metallation reaction with a group 4 metal compound, MX14or MX14(THF)2can proceed by direct protonolysis by the phosphinimine compound where at least one and in some cases two X1is / are a protonolyzable group.

[0289] Examples of protonolyzable groups, X1, may in embodiments of the disclosure include an amido group of the formula -NR€2 wherein each R€is independently selected from the group consisting of hydrogen, C1.20 alkyl group, and C6-20 aryl group.

[0290] In another embodiment of the disclosure a metallation reaction with a group 4 metal compound, MX14or MX14(THF)2can proceed by the deprotonation, or double deprotonation of the phosphinimine compound using a base, followed by electrophilic abstraction of at least one and in some cases two X1group / groups. Examples of groups, X1which can be electrophilically abstracted, may in embodiments of the disclosure include a halide, an alkoxy group, an aryloxy group, an alkylaryloxy group, and an arylalkyloxy group.

[0291] In embodiments, each X1is independently selected from a chloride, a dimethylamido group and a diethylamido group.

[0292] In embodiments, each X1is a halide.

[0293] In embodiments, each X1is a dimethylamido group or a diethylamido group.

[0294] In embodiments each X1is chloride.

[0295] In embodiments, the base used to carry out the deprotonation or double deprotonation of the phosphinimine compound is selected from organic alkali metal compounds, such as for example, organolithium compounds which include methyl lithium, ethyl lithium, n-butyl lithium, sec-butyl lithium, tert-butyl lithium, lithium

[0296] trimethyl silylacetylide, lithium acetylide, trimethyl silylmethyl lithium, vinyl lithium, phenyl lithium and allyl lithium. In embodiments, the base used to carry out the deprotonation or double deprotonation of the phosphinimine compound is n-butyl lithium or tert-butyl lithium.

[0297] In some embodiments, the base may be used in combination with an amine compound. Such an amine compound includes primary amine compounds such as methylamine, ethylamine, n-propylamine, isopropylamine, n-butylamine, tert-butylamine, n-octylamine, n-decylamine, aniline and ethylenediamine, secondary amine compoundssuch as dimethylamine, diethylamine, di-n-propylamine, di-n-butylamine, di-tert-butylamine, di-n-octylamine, di-n-decylamine, pyrrolidine, hexamethyldisilazane and diphenylamine, and tertiary amine compounds such as trimethylamine, triethylamine, tri-n-propylamine, tri-n-butylamine, diisopropylethylamine, tri-n-octylamine, tri-n-decylamine, triphenylamine, N, N-dimethylaniline, N, N, N', N' -tetramethylethylenediamine, N-methylpyrrolidine and 4-dimethylaminopyridine.

[0298] Representative, non-limiting examples of metallation reactions which can be used in embodiments of the present disclosure to make organometallic complexes which may serve as pre-polymerization catalysts include:

[0299] RBRB

[0300]

[0301] , where M, RA, RB, and RCare as defined in the embodiments above;

[0302]

[0303] cyclopentadienyl, and M, RA, RB, and RCare as defined in the embodiments above;

[0304]

[0305] R1, R2, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17and R18are as defined in the embodiments above;

[0306]

[0307] R1, R2, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17and R18are as defined in the embodiments above; and

[0308]

[0309] R1, R2, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17and R18are as defined in the embodiments above.

[0310] A person skilled in the art will know that pre-polymerization catalysts having halide ligands may be transformed into pre-polymerization catalysts having alkyl ligands by treatment with alkylating reagents. For example, and in embodiments of the disclosure, a dichloride organometallic complex (e.g. a dichloride pre-polymerization catalyst) may be converted into a dimethyl organometallic complex (e.g. a dimethyl pre-polymerization complex) by treatment with an alkyl lithium reagent such as methyllithium or with a Grignard reagent such as methylmagnesium bromide as shown below:

[0311]

[0312] R1, R2, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17and R18are as defined in the embodiments above.

[0313] Persons skilled in the art will understand that each of the forgoing chemical reactions can be carried out in a variety of solvents, including mixtures of different solvents. In embodiments of the disclosure a solvent or mixture of solvents can be selected from various polar and non-polar solvents, including aprotic solvents and a person skilled in the art will know how to select an appropriate solvent for a particular combination of reactants, or determine an appropriate solvent by routine experiment.Reaction solvents which can be used in embodiments of the disclosure include those selected from the group consisting of methanol, ethanol, di chloromethane, 1,2-di chloroethane, diethyl acetate, pyridine, acetone, dimethylformamide, dimethyl sulfoxide, acetonitrile, aromatic hydrocarbon solvents such as benzene, o-xylene, or toluene, aliphatic hydrocarbon solvents such as hexane or heptane, ether solvents such as diethyl ether, tetrahydrofuran or 1,4-di oxane, amide solvents such as hexamethylphosphoric amide or dimethylformamide, propionitrile, diethyl ketone, methyl isobutyl ketone, cyclohexanone, chlorobenzene, and di chlorobenzene. In embodiments, these solvents may be used alone or as a mixture of two or more of them.

[0314] Persons skilled in the art will understand that the forgoing chemical reactions can be carried out at ambient temperatures, temperatures above ambient temperature or they can be carried out at temperatures below ambient temperature.

[0315] In embodiments, the compounds made in the forgoing chemical reactions may sometimes be isolated from a reaction mixture using conventional methods, such as, filtration, extraction, precipitation, crystallization, recrystallization, removing solvents under vacuum, washing with solvent or diluent, and the like, as well as combinations thereof.

[0316] EXAMPLES

[0317] General Experimental Methods

[0318] All reactions involving air- and / or moisture-sensitive compounds were conducted under nitrogen using standard Schlenk techniques or in an inert atmosphere glovebox; reaction solvents were purified using the system described by Pangborn et al. (Pangborn, A. B. G.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518) and then stored over activated molecular sieves in an inert atmosphere glovebox, with the following exceptions: methanol (99.8%, GR ACS ACS) was purchased from VWR and sparged with N2 prior to use; acetonitrile was purchased from VWR, sparged with N2 and stored over activated alumina prior to use; triethylamine was purchased from Sigma-Aldrich, dried over KOH and distilled prior to use; isopropanol was purchased from Sigma-Aldrich and distilled over sodium prior to use; cyclopentyl methyl ether (anhydrous) was purchased from Sigma-Aldrich, sparged with N2 and stored over activated alumina prior to use; 1,2-dimethoxy ethane was purchased from Alfa Aesar, sparged with N2 and stored over activated alumina prior to use. Solvents for air- and moisture-stable reactions were purchased from VWR and used as received. Deuterated solvents were purchased from CIL and stored over activated 13x molecular sieves. Celite was purchased from Sigma- Aldrich,oven-dried, and stored in the glovebox for use with moisture-sensitive chemistry. All chemicals were purchased from Sigma-Aldrich and used without further purification, with the exception of O-(4-nitrobenzoyl)hydroxylamine and O-(2,4-dinitrophenyl)hydroxylamine which were purchased from Ambeed, and Aliquat 336 TG which was purchased from Alfa Aesar. Deuterated solvents were purchased from Cambridge Isotope Laboratories (toluene-ds) and were stored over activated 4 A molecular sieves. NMR spectra were recorded on Bruker 400 MHz spectrometers (400.1 MHz for 'H and 162 MHz for31P).

[0319] Preparation of di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)-l5-phosphanimine (Method A)

[0320] toluene / MeOH (1: 1), RT, overnight ii)nBuLi, then MeOH

[0321]

[0322]

[0323] At room temperature, to a 500 mL Schlenk flask containing di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)phosphane (19.1 g, 38.3 mmol) in toluene (95 mL) was added hydroxylamine-O-sulfonic acid (4.76 g, 42.1 mmol) in MeOH (95 mL). The reaction mixture was then stirred at room temperature for overnight. All solvents were removed under reduced pressure. THF (95 mL) was added to redissolve the residue, followed by the addition of w-BuLi (55.1 mL, 1.6 M in hexane, 88.1 mmol) dropwise until bright red color was observed. After quenching with MeOH (12.3 g, 383 mmol) and removal of solvents, the residue was extracted with toluene. The filtrate was dried under reduced pressure to afford di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)-l5-phosphanimine as a pale yellow solid. Yield: 19.0 g, 97%. Purity: 95%. Further washing the solid with n-pentane gave di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)-l5-phosphanimine with purity of 99%. 'H NMR (ds-toluene): 57.72 (d, J= 8.1 Hz, 2H), 7.55 (d, J= 1.8 Hz, 2H), 7.51 (m, 1H), 7.35 (dd, J= 8.1, 1.8 Hz, 2H), 6.78 (m, 1H), 6.64 (m, 1H), 6.52 (ddd, J= 8.1, 3.3, 1.4 Hz, 1H), 1.38 (s, 9H), 1.35 (s, 9H), 1.24 (s, 18H).31P{1H} NMR (d8-toluene): δ 48.1.Preparation of di-ferLbutyl(2-(2,7-di-terLbutyl-9H-fluoren-9-yl)phenyl)-l5-phosphanimine (Method B)

[0324]

[0325] At room temperature, to a Schlenk flask containing di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)phosphane (1 g, 2.01 mmol) in THF (25 mL) was added O-(4-Nitrobenzoyl)hydroxylamine (365 mg, 2.01 mmol) in THF (25 mL). The reaction mixture was then stirred at room temperature for 1 hour. KHMDS (400 mg, 2.01 mmol) in THF (2 mL) was added slowly to quench the reaction. After removal of solvents, the residue was washed with / / -pentane (20 mL) and then was extracted with toluene. The filtrate was dried under reduced pressure to afford di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)-l5-phosphanimine as a pale-yellow to off-white solid. Yield: 650 mg, 63%. Purity: >99%.

[0326] Reaction Condition Screening Examples (PART A): Electrophilic Amination of a Phosphine Compound Utilizing Hydroxylamine-O-Sulfonic Acid.

[0327] Di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)phosphane (100 mg, 0.20 mmol) in solvent A (3 mL unless otherwise stated, slurry / solution) in a 10-mL vial was mixed with hydroxylamine-O-sulfonic acid (24.9 mg, 0.22 mmol) in solvent B (3 mL unless otherwise stated, slurry / solution) in a 10-mL vial. The vial was sealed, and the mixture stirred at room temperature (“RT” in Table 1) or 50°C. In the case of 50°C reactions, the headspace was evacuated briefly. (Overall reagent concentration was ~ 66 mM). Aliquots were analyzed by NMR at certain time intervals.31P NMR (unlocked) resonances at δ 65 – 55 were interpreted as P=N bond containing phosphinimine product compounds (“£P” in Table 1);31P NMR (unlocked) resonances at δ 31 – 10 were interpreted as phosphine compound starting materials (“ SM” in Table 1); and other31P NMR (unlocked) resonance peaks which were observed were considered by-products (“ BP” in Table 1).TABLE 1

[0328]

[0329]

[0330]

[0331]

[0332] NOTE 1: NEt3 was added with no observable effect in the31P NMR;

[0333] NOTE 2: KHMDS was added resulting in deprotonation as evidenced by a change in the31P NMR signal of δ 61 to δ 53;

[0334] NOTE 3: KHMDS was added resulting in deprotonation as evidenced by a change in the31P NMR signal of δ 29 to δ 16. DME = dimethoxyethane; MeCN = acetonitrile; CPME = cyclopentyl methyl ether; THF = tetrahydrofuran;

[0335] ALIQUAT® 336 TG is a phase transfer catalyst.

[0336] A person skilled in the art will understand that the data in Table 1 shows that relatively electronic rich phosphine compounds (e.g. trihydrocarbyl phosphine compounds having at least one primary, secondary, or tertiary alkyl group present) can be converted into phosphinimide compounds using the electrophilic amination methods of the present disclosure.Reaction Condition Screening Examples (PART B): Reaction of Various Phosphine Compounds with Various Hydroxylamine Reagents

[0337]

[0338] A toluene, or THF solution of the phosphine compound A (di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)phosphane), or phosphine compound D (di(adamantan-l-yl)(butyl)phosphane)) (1.0 mL, 0.040 M, 0.040 mmol) was dispensed into 8 mL vials. For compounds which contained two phosphorus centers, compound B ((oxybis(2,l-phenylene))bis(diphenylphosphane)), or compound C (di-tert-butyl(2-(diisopropylphosphaneyl)phenyl)phosphane), half the amount was dispensed (0.50 mL, 0.040 M, 0.002 mmol), so that the ratio of the hydroxylamine reagent (i.e. the electrophilic aminating agent) and phosphorus atoms remained consistent. A THF, or methanol solution of the electrophilic aminating agent E (O-(4-nitrobenzoyl)hydroxylamine), F ((aminooxy)diphenylphosphine oxide), G ((aminooxy)diphenylphosphine oxide), or H (HOSA) (1 mL, 0.044 M, 0.044 mmol) was dispensed into the stirring phosphine solution. In the case of o-diphenylphosphinylhydroxylamine, a suspension was added due to the insolubility of this compound in THF or MeOH. The vials were sealed and the mixtures were stirred for 2 days at room tempereature. The solutions (1 mL) were transferred into NMR tubes and the 31P{1H} NMR acquired. For the diphosphines, signals associated with the monophosphiniminium cation were included in the “starting material” column (“ SM” in Table 2). The desired P=N bond containing phosphinimine or diphosphinimine product compounds are “ P” in Table 2 whereas “ BP” is for biproducts.

[0339]

[0340]

[0341] A person skilled in the art will understand that the data in Table 2 shows that various phosphine compounds, including diphosphines can be converted into phosphinimide compounds using the electrophilic amination methods of the present disclosure.

[0342] Preparation of Complex 1

[0343]

[0344] Complex 1 To di-tert-butyl(2-(2,7-di-tert-butyl-9H-fluoren-9-yl)phenyl)-l5-phosphanimine (21 g, 40 mmol) in toluene (200 mL) in a 500-mL Kontes flask cooled at 0°C (an ice bath) was added w-BuLi (52.4 mL, 1.6 M in hexane, 83.4 mmol). The reaction mixture became red and opaque and was stirred for 20 minutes, after which TiC14(THF)2 (13.57 g, 40 mmol) in toluene (130 mL) was added and the mixture allowed to warm to ambient temperature and stirred overnight. The volatiles were removed under reduced pressure to give a dark red residue, which was extracted with dichloromethane (600 mL), then toluene (200 mL) and filtered through a pad of Celite on a sintered-glass funnel. The combined filtrates were concentrated to -100 mL, filtered through a sintered-glass funnel, and the filter cake rinsed with toluene (20 mL) and pentane (3 x 30 mL) to give a red solid. Yield: 21.4 g, 83%. 'H NMR (ds-toluene): 57.76 (d, J= 8.65 Hz, 3H), 7.94 (m, 2H), 7.55 (dd, J= 8.9, 1.8 Hz, 2H), 7. 39 (m, 1H), 7.43 (t, J= 7.61Hz, 1H), 7.18 (m, 2H), 7.04 (m, 3H), 1.29 (s, 18H), 1.12 (s, 9H), 1.08 (s, 9H). ^P H} NMR (ds-toluene): δ 31.6.Preparation of Complex 2

[0345]

[0346] To Complex 1 (21.4 g, 33.9 mmol) in toluene (200 mL) in a 500-mL round-bottomed flask was added methylmagnesium bromide (36.0 mL, 3 M in diethyl ether, 101.8 mmol) via cannula and the stirred for 30 minutes. The volatiles were removed under reduced pressure to give a yellow brown residue. The residue was mixed with pentane (200 mL), stirred for 10 minutes, and the solvent removed to give a yellow-brown powder. This was repeated twice more. Afterwards, toluene (300 mL) was added, and the mixture filtered through a pad of Celite on a sintered-glass funnel, and the filter cake rinsed with additional toluene (3 x 100 mL). The filtrates were combined, and the volatiles were removed under reduced pressure to give a yellowish solid which was washed with pentane (2 x 60 mL), and then dried under vacuum to give a yellow powder. Yield: 15.5 g, 77%.1H NMR (d8-toluene): δ 8.15 (d, J= 8.83, 2H), 7.52 (t, J= 8.10 Hz, 1H), 7.41 (dd, J= 8.87 Hz, 1.72 Hz, 2H), 7.23-7.17 (m, 1H), 7.08-6.97 (m, 2H), 6.87 (s, 2H), 1.22 (s, 18H), 1.20 (d, J= 14.7 Hz, 18H), -0.31 (s, 6H). ^P H} NMR (ds-toluene): δ 24.68.

[0347] Non-limiting embodiments of the present disclosure include the following:

[0348] Embodiment 1. A method for making a phosphinimine compound having the formula I,

[0349]

[0350] the method comprising:

[0351] combining a phosphine compound having the formula II,

[0352]

[0353] hydroxylamine reagent and a Bronsted base;wherein the hydroxylamine reagent is selected from the group consisting of:

[0354] 0

[0355] HO - y_O— NH2

[0356] (Illa),

[0357]

[0358] ( );

[0359] wherein each R* is independently a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group;

[0360] wherein RAis a primary alkyl group, or a secondary alkyl group, or a tertiary alkyl group; and

[0361] wherein RBand RCare each independently selected froma hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a Ci-3o alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and

[0362] a heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group.

[0363] Embodiment 2. The method of Embodiment 1, wherein each R* is independently an aryl group, which aryl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0364] Embodiment 3. The method of Embodiment 1, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0365] Embodiment 4. The method of Embodiment 1, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitro group.

[0366] Embodiment 5. The method of Embodiment 1, wherein each R* is independently an unsubstituted phenyl group.

[0367] Embodiment 6. The method of Embodiment 1, wherein each R* is an alkyl group, which alkyl group is unsubstituted or further substituted by one or more than one fluorine atom.Embodiment 7. The method of Embodiment 1, wherein the hydroxylamine reagent 0

[0368] HO - y_ o— NH2

[0369] is ” (Illa).

[0370] Embodiment 8. The method of any of Embodiments 1 to 7, wherein RBand RCare each independently selected from a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0371] Embodiment 9. The method of any one of Embodiments 1 to 7, wherein RBand RCare each, independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

[0372] Embodiment 10. The method of any one of Embodiments 1 to 7, wherein RAand RBand RCare each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

[0373] Embodiment 11. The method of any one of Embodiments 1 to 7, wherein RAand RBand RCare each independently selected from the group consisting of an isopropyl group, a cyclohexyl group, an adamantly group, and a tert-butyl group.

[0374] Embodiment 12. The method of any one of Embodiments 1 to 7, wherein RAand RBand RCare each an isopropyl group.

[0375] Embodiment 13. The method of any one of Embodiments 1 to 7, wherein RAand RBand RCare each a cyclohexyl group.

[0376] Embodiment 14. The method of any one of Embodiments 1 to 7, wherein RAand RBand RCare each a tert-butyl group.

[0377] Embodiment 15. The method of any one of Embodiments 1 to 7, wherein RAand RBand RCare each an adamantyl group.

[0378] Embodiment 16. A method for making a phosphinimine compound having the formula IV,

[0379]

[0380] double bond isomers of formula IV which are available by migration of the hydrogen, H* within the cyclopentadiene ring structure; the method comprising:

[0381] combining a phosphine compound having the formula V,

[0382]

[0383] hydroxylamine reagent and a Bronsted base; wherein the hydroxylamine reagent is selected from the group consisting of:

[0384] (Illa),

[0385]

[0386] (Illb),

[0387] 0

[0388] R. — y_ o_ NH2(IIIc)

[0389]

[0390] wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and wherein R1and R2are each independently a C1.30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0391] wherein R3, R4, R5and R6are each independently selected from the group consisting of

[0392] a hydrogen atom;

[0393] a fluorine atom;

[0394] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20arylalkyl group, a Ce-20 aryl group, a Ce-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0395] a heteroatom containing C1-30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1-20 alkyl group, a C1-20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0396] wherein two adjacent groups of R3, R4, R5and R6may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1-20 alkyl group, a C1-20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group; and

[0397] wherein L is a bridging group.

[0398] Embodiment 17. The method of Embodiment 16, wherein each R* is independently an aryl group, which aryl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1-20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a Ce-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0399] Embodiment 18. The method of Embodiment 16, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a fluorine atom, a nitrile group, a nitro group, a C1-20 alkyl group, a C1-20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a Ce-20 aryl group, a Ce-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0400] Embodiment 19. The method of Embodiment 16, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitro group.

[0401] Embodiment 20. The method of Embodiment 16, wherein each R* is independently an unsubstituted phenyl group.Embodiment 21. The method of Embodiment 16, wherein each R* is an alkyl group, which alkyl group is unsubstituted or further substituted by one or more than one fluorine atom.

[0402] Embodiment 22. The method of Embodiment 16, wherein the hydroxylamine

[0403] reagent i

[0404]

[0405] (Illa).

[0406] Embodiment 23. The method of any one of Embodiments 16 to 22, wherein R1and R2are each independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

[0407] Embodiment 24. The method of any one of Embodiments 16 to 22, wherein R1and R2are each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

[0408] Embodiment 25. The method of any one of Embodiments 16 to 22, wherein R1and R2are each independently selected from the group consisting of isopropyl, cyclohexyl, adamantly, and tert-butyl.

[0409] Embodiment 26. The method of any one of Embodiments 16 to 22, wherein R1and R2are each an isopropyl group.

[0410] Embodiment 27. The method of any one of Embodiments 16 to 22, wherein R1and R2are each a cyclohexyl group.

[0411] Embodiment 28. The method of any one of Embodiments 16 to 22, wherein R1and R2are each a tert-butyl group.

[0412] Embodiment 29. The method of any one of Embodiments 16 to 22, wherein R1and R2are each an adamantyl group.

[0413] Embodiment 30. The method of of any one of Embodiments 16 to 29, wherein L is

[0414]

[0415] indicates the point of attachment to P and (*) indicates the point of attachment to the cyclopentadiene ring structure;wherein R7, R8, R9, and R10are each independently selected from the group consisting of

[0416] a hydrogen atom;

[0417] a fluorine atom;

[0418] a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0419] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0420] wherein two adjacent groups of R7, R8, R9, and R10may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0421] Embodiment 31. The method of Embodiment 30, wherein R7, R8, R9, and R10are each hydrogen.

[0422] Embodiment 32. A method for making a phosphinimine compound having the formula VI,

[0423]

[0424] the method comprising:

[0425] combining a phosphine compound having the formula VII,

[0426]

[0427] hydroxylamine reagent and a Bronsted base;

[0428] wherein the hydroxylamine reagent is selected from the group consisting of: 0

[0429] HO - y_ o— NH2

[0430] (Illa),

[0431]

[0432] (IIIe),

[0433]

[0434] wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and wherein R1and R2are each independently a C1.30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0435] wherein R11, R12, R13, R14, R15, R16, R17and R18are each independently selected from the group consisting of

[0436] a hydrogen atom;

[0437] a fluorine atom;

[0438] a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and

[0439] a heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0440] wherein two adjacent groups of R11, R12, R13, R14, R15, R16, R17and R18may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containinghydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; and wherein L is a bridging group.

[0441] Embodiment 33. The method of Embodiment 32, wherein each R* is independently an aryl group, which aryl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0442] Embodiment 34. The method of Embodiment 32, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a fluorine atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0443] Embodiment 35. The method of Embodiment 32, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitro group.

[0444] Embodiment 36. The method of Embodiment 32, wherein each R* is independently an unsubstituted phenyl group.

[0445] Embodiment 37. The method of Embodiment 32, wherein each R* is an alkyl group, which alkyl group is unsubstituted or further substituted by one or more than one fluorine atom.

[0446] Embodiment 38. The method of Embodiment 32, wherein the hydroxylamine

[0447] O HO - y — O— NH2

[0448] reagent is0(Illa).Embodiment 39. The method of any one of Embodiments 32 to 38, wherein R1and R2are each independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

[0449] Embodiment 40. The method of any one of Embodiments 32 to 38, wherein R1and R2are each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

[0450] Embodiment 41. The method of any one of Embodiments 32 to 38, wherein R1and R2are each independently selected from the group consisting of isopropyl, cyclohexyl, adamantly, and tert-butyl.

[0451] Embodiment 42. The method of any one of Embodiments 32 to 38, wherein R1and R2are each an isopropyl group.

[0452] Embodiment 43. The method of any one of Embodiments 32 to 38, wherein R1and R2are each a cyclohexyl group.

[0453] Embodiment 44. The method of any one of Embodiments 32 to 38, wherein R1and R2are each a tert-butyl group.

[0454] Embodiment 45. The method of any one of Embodiments 32 to 38, wherein R1and R2are each an adamantyl group.

[0455] Embodiment 46. The method of any one of Embodiments 32 to 45, wherein L is

[0456]

[0457] wherein ∿∿∿∿ indicates the point of attachment to P and (*) indicates the point of attachment to the cyclopentadiene ring structure;

[0458] wherein R7, R8, R9, and R10are each independently selected from the group consisting of

[0459] a hydrogen atom;

[0460] a fluorine atom;

[0461] a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; anda heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;

[0462] wherein two adjacent groups of R7, R8, R9, and R10may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

[0463] Embodiment 47. The method of Embodiment 46, wherein R7, R8, R9, and R10are each hydrogen.

[0464] INDUSTRIAL APPLICABILITY

[0465] Methods for making phosphinimine compounds are provided. The phosphinimine compounds may be used to prepare single site polymerization catalysts which find application in olefin polymerization processes.

Claims

CLAIMS1. A method for making a phosphinimine compound having the formula I,the method comprising:combining a phosphine compound having the formula II,with a hydroxylamine reagent and a Bronsted base;wherein the hydroxylamine reagent is selected from the group consisting of:0HO - y_ o— NH2(Illa),(Illf);wherein each R* is independently a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1-30 alkyl group, a C1-30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group;wherein RAis a primary alkyl group, or a secondary alkyl group, or a tertiary alkyl group; andwherein RBand RCare each independently selected from:a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1-30 alkyl group, a C1-30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a Ce-30 aryl group, a Ce-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; anda heteroatom containing hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a C1-30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a Ce-30 aryl group, a Ce-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group.

2. The method of claim 1, wherein each R* is independently an aryl group, which aryl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1-20 alkyl group, a C1-20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a Ce-20 aryl group, a Ce-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

3. The method of claim 1, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1-20 alkyl group, a Ci- 20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

4. The method of claim 1, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitro group.

5. The method of claim 1, wherein each R* is independently an unsubstituted phenyl group.

6. The method of claim 1, wherein each R* is an alkyl group, which alkyl group is unsubstituted or further substituted by one or more than one fluorine atom.

7. The method of claim 1, wherein the hydroxylamine reagent is(Illa).

8. The method of claim 1, wherein RBand RCare each independently selected from: a hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a Ci-2o alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

9. The method of claim 1, wherein RBand RCare each, independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

10. The method of claim 1, wherein RAand RBand RCare each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

11. The method of claim 1, wherein RAand RBand RCare each independently selected from the group consisting of an isopropyl group, a cyclohexyl group, an adamantly group, and a tert-butyl group.

12. The method of claim 1, wherein RAand RBand RCare each an isopropyl group.

13. The method of claim 1, wherein RAand RBand RCare each a cyclohexyl group.

14. The method of claim 1, wherein RAand RBand RCare each a tert-butyl group.

15. The method of claim 1, wherein RAand RBand RCare each an adamantyl group.

16. A method for making a phosphinimine compound having the formula IV,or double bond isomers of formula IV which are available by migration of the hydrogen, H* within the cyclopentadiene ring structure;the method comprising:combining a phosphine compound having the formula V,with a hydroxylamine reagent and a Bronsted base;wherein the hydroxylamine reagent is selected from the group consisting of:0HO - y_ o— NH2(Illa),(Illb),0R- - y_0_NH2 (IIIc)wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; and wherein R1and R2are each independently a C1.30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;wherein R3, R4, R5and R6are each independently selected from the group consisting ofa hydrogen atom;a fluorine atom;a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20arylalkyl group, a Ce-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; anda heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;wherein two adjacent groups of R3, R4, R5and R6may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, a C7-20 arylalkyloxy group; andwherein L is a bridging group.

17. The method of claim 16, wherein each R* is independently an aryl group, which aryl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

18. The method of claim 16, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a fluorine atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

19. The method of claim 16, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitro group.

20. The method of claim 16, wherein each R* is independently an unsubstituted phenyl group.

21. The method of claim 16, wherein each R* is an alkyl group, which alkyl group is unsubstituted or further substituted by one or more than one fluorine atom.

22. The method of claim 16, wherein the hydroxylamine reagent is(Illa).

23. The method of claim 16, wherein R1and R2are each independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

24. The method of claim 16, wherein R1and R2are each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

25. The method of claim 16, wherein R1and R2are each independently selected from the group consisting of isopropyl, cyclohexyl, adamantly, and tert-butyl.

26. The method of claim 16, wherein R1and R2are each an isopropyl group.

27. The method of claim 16, wherein R1and R2are each a cyclohexyl group.

28. The method of claim 16, wherein R1and R2are each a tert-butyl group.

29. The method of claim 16, wherein R1and R2are each an adamantyl group.

30. The method of claim 16, wherein L iswherein ∿∿∿∿ indicates the point of attachment to P and (*) indicates the point of attachment to the cyclopentadiene ring structure;wherein R7, R8, R9, and R10are each independently selected from the group consisting ofa hydrogen atom;a fluorine atom;a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; anda heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;wherein two adjacent groups of R7, R8, R9, and R10may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

31. The method of claim 30, wherein R7, R8, R9, and R10are each hydrogen.

32. A method for making a phosphinimine compound having the formula VI,the method comprising:combining a phosphine compound having the formula VII,with a hydroxylamine reagent and a Bronsted base;wherein the hydroxylamine reagent is selected from the group consisting of:wherein each R* is independently a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.30 alkyl group, a C1.30 alkoxy group, a C7-30 alkylaryl group, a C7-30 arylalkyl group, a C6-30 aryl group, a C6-30 aryloxy group, a C7-30 alkylaryloxy group, and a C7-30 arylalkyloxy group; andwherein R1and R2are each independently a C1.30 hydrocarbyl group which is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;wherein R11, R12, R13, R14, R15, R16, R17and R18are each independently selected from the group consisting ofa hydrogen atom;a fluorine atom;a C1.30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; anda heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;wherein two adjacent groups of R11, R12, R13, R14, R15, R16, R17and R18may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; andwherein L is a bridging group.

33. The method of claim 32, wherein each R* is independently an aryl group, which aryl group is unsubstituted or further substituted by one or more substituent selected from the group consisting of a halide atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

34. The method of claim 32, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more substituent selectedfrom the group consisting of a fluorine atom, a nitrile group, a nitro group, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

35. The method of claim 32, wherein each R* is independently a phenyl group, which phenyl group is unsubstituted or further substituted by one or more than one nitro group.

36. The method of claim 32, wherein each R* is independently an unsubstituted phenyl group.

37. The method of claim 32, wherein each R* is an alkyl group, which alkyl group is unsubstituted or further substituted by one or more than one fluorine atom.

38. The method of claim 32, wherein the hydroxylamine reagent is0HO - y_O— NH2O (Illa).

39. The method of claim 32, wherein R1and R2are each independently selected from the group consisting of a primary alkyl group, a secondary alkyl group, and a tertiary alkyl group.

40. The method of claim 32, wherein R1and R2are each independently selected from the group consisting of a secondary alkyl group, and a tertiary alkyl group.

41. The method of claim 32, wherein R1and R2are each independently selected from the group consisting of isopropyl, cyclohexyl, adamantly, and tert-butyl.

42. The method of claim 32, wherein R1and R2are each an isopropyl group.

43. The method of claim 32, wherein R1and R2are each a cyclohexyl group.

44. The method of claim 32, wherein R1and R2are each a tert-butyl group.

45. The method of claim 32, wherein R1and R2are each an adamantyl group46. The method of claim 32, wherein L iswherein ∿∿∿∿ indicates the point of attachment to P and (*) indicates the point of attachment to the cyclopentadiene ring structure;wherein R7, R8, R9, and R10are each independently selected from the group consisting ofa hydrogen atom;a fluorine atom;a C1-30 hydrocarbyl group, which hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group; anda heteroatom containing C1.30 hydrocarbyl group, which heteroatom containing hydrocarbyl group is unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group;wherein two adjacent groups of R7, R8, R9, and R10may optionally be bonded to form a cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group, the cyclic hydrocarbyl group or cyclic heteroatom containing hydrocarbyl group being unsubstituted or further substituted by one or more than one substituent selected from the group consisting of a fluorine atom, a C1.20 alkyl group, a C1.20 alkoxy group, a C7-20 alkylaryl group, a C7-20 arylalkyl group, a C6-20 aryl group, a C6-20 aryloxy group, a C7-20 alkylaryloxy group, and a C7-20 arylalkyloxy group.

47. The method of claim 46, wherein R7, R8, R9, and R10are each hydrogen.